Bipolar disorder is treated with a combination of mood-stabilizing medications, psychotherapy, and lifestyle strategies that work together to control mood episodes and prevent relapses. Most people need medication as the foundation of their treatment plan, with therapy and daily habit changes layered on top. The specific approach depends on whether you’re managing an acute episode of mania or depression, or trying to stay stable long-term.
Mood Stabilizers: The Foundation
Lithium remains the treatment of choice for classic euphoric mania, the type characterized by an elevated, expansive mood rather than a mixed or depressed state. It takes about five days to reach a steady level in your body, so during an acute episode it’s often paired with faster-acting medications to bridge the gap. Lithium also has a unique benefit: it’s a proven antisuicidal agent, which makes it especially valuable for people at higher risk.
Valproic acid is another core mood stabilizer, and it’s frequently used for acute mania because it can be adjusted to an effective level much more quickly than lithium. Carbamazepine is a third option in this class, though it’s typically reserved for cases where lithium and valproic acid aren’t feasible or well-tolerated.
For long-term maintenance, the goal shifts from putting out a fire to preventing the next one. The WHO recommends that adults with bipolar disorder in remission continue on a mood stabilizer or an oral antipsychotic, balancing effectiveness, side effects, and personal preference. This is not a short-term commitment. Most people stay on maintenance treatment indefinitely because stopping medication is one of the most common triggers for relapse.
Lamotrigine for Bipolar Depression
Lamotrigine fills a gap that other mood stabilizers leave open. While lithium and valproic acid are strongest at preventing mania, lamotrigine is particularly useful for the depressive side of bipolar disorder. In clinical studies using daily doses between 100 mg and 500 mg, lamotrigine performed about as well as lithium at preventing depressive episodes and reducing the need for additional medications. It didn’t show a significant difference from placebo in preventing depressive recurrence at one year, but it remains a widely used option, especially for people with Bipolar II disorder, where depression dominates the illness more than mania does.
Lamotrigine has a reputation for being better tolerated than many other mood stabilizers, which matters a lot when someone needs to take a medication for years. It requires a slow, gradual dose increase to reduce the risk of a serious skin reaction, so it’s not a quick fix for an acute episode.
Antipsychotics for Acute Episodes and Beyond
Several antipsychotic medications now play a central role in bipolar treatment, both during acute episodes and for ongoing maintenance. Aripiprazole, olanzapine, quetiapine, and risperidone are all recommended options for long-term stability.
For bipolar depression specifically, the FDA has approved a handful of treatments. Quetiapine was approved as a standalone treatment for bipolar depressive episodes in 2006 and has some of the strongest data behind it. In combined clinical trials, it produced effect sizes of 0.78 to 0.80 (considered large), meaning it separated clearly from placebo over eight weeks of treatment. It works for both Bipolar I and Bipolar II depression, though its effects are stronger in Bipolar I.
Lurasidone was approved for Bipolar I depression and can be used alone or added to lithium or valproic acid. In studies, about one in five additional patients responded to lurasidone compared to placebo (a “number needed to treat” of 5), which is a solid result for psychiatric medication. When added to an existing mood stabilizer, it still produced meaningful improvement over placebo.
An olanzapine-fluoxetine combination was the first FDA-approved treatment for Bipolar I depression, gaining approval in 2003. It achieved a response rate of 56% and a remission rate of about 49%, both significantly higher than placebo. Olanzapine alone, notably, is not approved for bipolar depression, though it showed modest benefit in the same trials.
What Happens During a Crisis
Acute mania often requires hospitalization. The threshold is straightforward: if the mood disturbance is severe enough to seriously impair your ability to function at work or socially, if there’s a risk of harm to yourself or others, or if psychotic symptoms are present, inpatient care is the standard approach.
In the hospital, treatment typically involves a mood stabilizer combined with an antipsychotic and sometimes a short-term sedating medication to help with sleep and agitation. Valproic acid is often preferred in this setting because it can be brought to an effective level quickly, while lithium takes longer to build up. The antipsychotic and sedating medication provide faster symptom control while the mood stabilizer takes hold. This layered approach is designed to stabilize the most dangerous symptoms within the first few days while building toward a longer-term medication plan.
Psychotherapy as a Treatment Layer
Medication manages the biology of bipolar disorder, but therapy addresses the patterns of behavior, thinking, and daily life that influence how often episodes occur and how severe they get. Several structured approaches have strong evidence behind them.
Interpersonal and Social Rhythm Therapy (IPSRT) is built specifically for mood disorders. It works by helping you develop more regular daily routines, because disruptions to your biological and social rhythms, things like inconsistent sleep schedules, irregular meals, and erratic social activity, can trigger mood episodes. IPSRT also focuses on improving medication adherence, managing stressful life events, and building skills that protect against future episodes. The core idea is that stabilizing your external rhythms helps stabilize your internal ones.
Cognitive behavioral therapy helps you identify thought patterns and behaviors that worsen mood episodes or interfere with treatment. Family-focused therapy brings loved ones into the process, improving communication and helping family members recognize early warning signs of an episode. All of these approaches work best alongside medication, not as replacements for it.
Sleep, Light, and Daily Rhythms
Sleep disruption is both a symptom and a trigger of bipolar episodes, which makes sleep management one of the most practical things you can do. Keeping a consistent sleep and wake schedule, even on weekends, helps anchor your circadian rhythms and reduce vulnerability to mood shifts.
An experimental approach called “dark therapy” takes this further. Researchers at the National Institute of Mental Health documented a case of rapid-cycling bipolar disorder that responded dramatically to enforced darkness, with no medications at all. The problem is that the original protocol, complete darkness from 6 p.m. to 8 a.m., is wildly impractical. A more realistic version uses amber-tinted lenses that block blue light, effectively creating “virtual darkness” for your brain while still allowing you to see. Preliminary case studies have shown that some people with bipolar disorder fall asleep faster with this approach, suggesting it influences circadian rhythms. This isn’t a mainstream treatment yet, but it highlights how powerfully light and darkness affect mood regulation in bipolar disorder.
Beyond sleep, general lifestyle strategies matter. Regular exercise, consistent meal timing, and limiting alcohol and caffeine all support mood stability. These aren’t substitutes for medication, but they reduce the number and severity of episodes for many people.
When Standard Treatment Doesn’t Work
For people whose bipolar depression doesn’t respond to multiple medication trials, electroconvulsive therapy (ECT) is a well-established option. In a randomized controlled trial comparing ECT to an optimized medication approach in treatment-resistant bipolar depression, ECT produced a response rate of 73.9%, compared to 35% for the medication group. That’s a striking difference. Depression scores dropped significantly more in the ECT group over six weeks of treatment.
ECT involves brief electrical stimulation of the brain under general anesthesia, typically two to three times per week for several weeks. It carries a reputation that’s worse than its reality. Modern ECT is far more refined than older versions, and the most common side effect is temporary memory difficulty around the time of treatment. For severe, medication-resistant depression, it remains one of the most effective tools available. Most treatment guidelines list it as a second-line option for refractory bipolar depression, meaning it’s recommended when first-line medications have failed.